Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 3Phase NA 2Phase 2/3 1Phase 2 1

Status

Completed 6Unknown 2Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 1Neoplasms 1Colorectal Neoplasms 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × Ketamine × Clear all
NCT03273231 2019-01-16

The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer Resection

Yonsei University

Phase NA Unknown
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01207206 2011-11-01

Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients

Tel-Aviv Sourasky Medical Center

Phase NA Unknown
50 enrolled

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡